.svg){kind=small}
Mar-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kikoko's performance in the California market showcases a varied trajectory across different product categories. In the beverage category, Kikoko maintained a consistent presence, ranking between 17th and 19th over the months from December 2024 to March 2025. This consistency indicates a stable demand, despite a slight dip in sales during February. In contrast, the brand's capsules have shown remarkable stability and strength, consistently holding the 5th position throughout the same period. This suggests a strong consumer base and possibly a leading position in this niche segment within the state.
In the edibles category, Kikoko's performance has been more volatile. Although they did not break into the top 30 brands initially, they showed a promising upward trend by March 2025, moving from 41st to 40th place. This gradual improvement could signal a growing acceptance or preference for their edible products. However, the brand's absence from the top 30 in earlier months highlights potential challenges in this competitive category. The contrasting performance across these categories underscores the importance of strategic focus and market adaptation for maintaining and enhancing brand presence.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Kikoko has maintained a consistent rank of 5th from December 2024 through March 2025. Despite this steady ranking, Kikoko has shown a positive sales trajectory, with sales increasing from December 2024 to March 2025. This upward trend in sales suggests a strengthening market presence, even as competitors like ABX / AbsoluteXtracts and Emerald Bay Extracts hold higher ranks at 3rd and 4th, respectively. Notably, Emerald Bay Extracts experienced a decline in sales over the same period, which could indicate potential opportunities for Kikoko to climb the ranks. Meanwhile, Heavy Hitters and Buddies have maintained lower rankings, with Heavy Hitters even dropping out of the top 20 in February 2025, highlighting Kikoko's resilience and potential for growth in this competitive market.
Notable Products
In March 2025, Kikoko's top-performing product was the XTabs Indica High Dose Tablets 20-Pack (1000mg) in the Capsules category, maintaining its number one rank from January. It achieved a notable sales figure of 3885 units. The XTabs Sativa High Dose Tablets 20-Pack (1000mg) closely followed, consistently holding the second position since February. The XTabs Hybrid High Dose Tablets 20-Pack (1000mg) remained stable in third place over the past four months. Meanwhile, Little Helpers CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin) and Little Helpers CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC) held steady at fourth and fifth positions, respectively, since December 2024.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
